Role of endocannabinoids in the regulation of the cardiovascular system, oxidative stres and heart metabolism in the models of primary and secondary hypertension

2012/05/B/NZ7/03102

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

Voivodeship: podlaskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Barbara Malinowska

Number of co-investigators in the project: 10

Call

OPUS 3 – announced on 2012-03-15

Amount awarded
842 550 PLN
Project start date
2013-01-25
Project end date
2016-07-24
Project duration
42 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Zbiornik z płaszczem grzejnym do buforu.
  2. Zestaw miografu drutowego (Multi Wire Myograph System - 620M, Danish Myo Technology-Ltd, Aarhus, Dania). Cost: 175 000 PLN

Information in the final report

Publication in academic press/journals (8)

  1. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.

    Authors:
    Pedzinska-Betiuk A, Weresa J, Toczek M, Baranowska-Kuczko M, Kasacka I, Harasim-Symbor E, Malinowska B.
    Academic press:
    British Journal of Pharmacology (year: 2017, volume: 174, pages: 2114-2129), Publisher: WILEY-BLACKWELL
    Status:
    Published
    DOI:
    10.1111/bph.13830 – link to the publication
  2. The endocannabinoid system affects myocardial glucose metabolism in the DOCA-Salt model of hypertension.

    Authors:
    Polak A, Harasim-Symbor E, Malinowska B, Kasacka I, Lewandowska A, Chabowski A.
    Academic press:
    Cellular Physiology and Biochemistry (year: 2018, volume: 46, pages: 727-739), Publisher: S. Karger AG, Basel
    Status:
    Published
    DOI:
    10.1159/000488730 – link to the publication
  3. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats

    Authors:
    Toczek M., Schlicker E., Grzęda E., Malinowska B.
    Academic press:
    Life Sciences (year: 2015, volume: 138, pages: 78-85), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.lfs.2015.03.022 – link to the publication
  4. The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats.

    Authors:
    Polak A, Harasim-Symbor E, Malinowska B, Kasacka I, Pędzińska-Betiuk A, Weresa J, Chabowski A.
    Academic press:
    Life Sciences (year: 2017, volume: 183, pages: 46032), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.lfs.2017.06.019 – link to the publication
  5. Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats.

    Authors:
    Toczek M, Baranowska-Kuczko M, Grzęda E, Pędzińska-Betiuk A, Weresa J, Malinowska B.
    Academic press:
    Pharmacological Reports (year: 2016, volume: 68, pages: 363-369), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2015.10.004 – link to the publication
  6. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.

    Authors:
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B.
    Academic press:
    Life Sciences (year: 2016, volume: 151, pages: 288-299), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.lfs.2016.03.014 – link to the publication
  7. Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance.

    Authors:
    Malinowska B, Toczek M, Pędzińska-Betiuk A, Schlicker E.
    Academic press:
    British Journal of Pharmacology (year: 2018, volume: 2018, pages: Epub ahead of print), Publisher: WILEY-BLACKWELL
    Status:
    Published
    DOI:
    10.1111/bph.14168 – link to the publication
  8. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on KCa2.3/KCa3.1-EDH-type relaxation in rat small mesenteric arteries.

    Authors:
    Kloza M, Baranowska-Kuczko M, Malinowska B, Karpińska O, Harasim-Symbor E, Kasacka I, Kozłowska H.
    Academic press:
    Vascular Pharmacology (year: 2017, volume: 99, pages: 65-73), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.vph.2017.10.001 – link to the publication

Articles in post-conference publications (11)

  1. Function of presynaptic inhibitory cannabinoid CB1 receptors on sympathetic nerves of spontaneously hypertensive rats

    Authors:
    Malinowska B., Toczek M., Kossakowsk R.i
    Conference:
    83rd Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) (year: 2017, pages: S36), Publisher: Springer
    Date:
    conference 06-09.03.
    Status:
    Published
    DOI:
    link to the publication
  2. Different physiological effects of chronic URB597 treatment in primary and secondary hypertension in rats

    Authors:
    Toczek M., Grzęda E., Pędzińska - Betiuk A., Weresa J., Kloza M., Baranowska - Kuczko M., Malinowska B.
    Conference:
    7th European Workshop on Cannabinoid Research and IACM 8th Conference on Cannabinoids in Medicine (year: 2015, pages: 56), Publisher: International Association for Cannabinoid Medicines
    Date:
    conference 17-19. 09.
    Status:
    Published
    DOI:
    link to the publication
  3. Different effects of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiac performance and oxidative stress in normotensive and hypertensive rats

    Authors:
    Malinowska B., Pędzińska-Betiuk A., Weresa J., Biernacki M., Toczek M., Baranowska-Kuczko M., Skrzydlewska E.
    Conference:
    26th Annual Symposium of the International Cannabinoid Research Society (year: 2016, pages: 13), Publisher: International Cannabinoid Research Society
    Date:
    conference 26. 06.- 01. 07.
    Status:
    Published
  4. Vascular effects of the chronic administration of FAAH inhibitor, URB597, in spontaneously hypertensive rats

    Authors:
    Baranowska-Kuczko M., Kozłowska H., Kloza M., Karpińska O., Kasacka I., Malinowska B.
    Conference:
    New Frontiers in Basic Cardiovascular Research, A France - new EU members symposium, Châtenay-Malabry, France (year: 2016, pages: w abastrakcie brak miejsca na żdródło finansowania), Publisher: University Paris-Sud
    Date:
    conference 03-06.07.
    Status:
    Published
  5. The pressor effect of cannabinoids in DOCA-salt hypertensive rats

    Authors:
    Grzęda E., Toczek M., Malinowska B.
    Conference:
    New Frontiers in Basic Cardiovascular Research 2014 (year: 2014, pages: 66), Publisher: Publishing & Printing House, Slovak Republic
    Date:
    conference 15 - 18.06.
    Status:
    Published
  6. Wpływ inhibitora rozkładu anandamidu URB597 na wybrane parametry izolowanego serca i lewego przedsionka szczurów z nadciśnieniem DOCA-salt

    Authors:
    Weresa J., Pędzińska-Betiuk, Toczek M., Malinowska B.
    Conference:
    XIX Sympozjum Kardiologii Eksperymentalnej (year: 2014, pages: 50), Publisher: Polskie Towarzystwo Kardiologiczne oraz Komitet Nauk Fizjologicznych i Farmakologicznych PAN
    Date:
    conference 6 - 8. 11.
    Status:
    Published
  7. Cannabidiol-induced vasorelaxation in isolated human pulmonary and small mesenteric arteries of hypertensive rat - preliminary study

    Authors:
    Baranowska-Kuczko M., Kozłowska M., Kloza M., Karpińska O., Toczek M., Kozłowski M., Malinowska B.
    Conference:
    26th Annual Symposium of the International Cannabinoid Research Society (year: 2016, pages: P1-19), Publisher: International Cannabinoid Research Society
    Date:
    conference 26. 06. 2016 - 01. 07. 2016
    Status:
    Published
  8. Effects of the chronic administration of FAAH inhibitor, URB597, on the cannabinoid-induced vasorelaxation in Doca-salt hypertensive rats

    Authors:
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Harasim E, Kasacka I, Malinowska B.
    Conference:
    7th European Workshop on Cannabinoid Research and IACM 8th Conference on Cannabinoids in Medicine (year: 2015, pages: 57), Publisher: International Association for Cannabinoid Medicines
    Date:
    conference 17-19. 09.
    Status:
    Published
    DOI:
    link to the publication
  9. Effects of endocannabinoid system activation on myocardial glucose metabolism in rat model of secondary hypertension.

    Authors:
    Polak A., Harasim-Symbor E., Malinowska B., Chabowski A.
    Conference:
    27th Congress of the Polish Physiological Society (year: 2017, pages: 65), Publisher: Polskie Towarzystwo Fizjologiczne
    Date:
    conference 21-22. 09.
    Status:
    Published
  10. Influence of FAAH inhibitor on the isoprenaline effects in isolated rat DOCA-salt hypertensive heart

    Authors:
    Pędzińska-Betiuk A., Skarżyńska J., Grzęda E., Malinowska B.
    Conference:
    New Frontiers in Basic Cardiovascular Research 2014 (year: 2014, pages: 85), Publisher: Publishing & Printing House, Slovak Republic
    Date:
    conference 15 - 18. 06.
    Status:
    Published
  11. CB1 receptors in the paraventricular nucleus of the hypothalamus elicit central sympathoexcitation.

    Authors:
    Malinowska B., Grzęda E., Schlicker E.
    Conference:
    6th European Workshop on Cannabinoid Research (year: 2013, pages: P051), Publisher: British Pharmacological Society
    Date:
    conference 18-20. 04.
    Status:
    Published
    DOI:
    link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski